Finally!!! After 3 year and 6 months of joining , after around 9 rejections, I got my first independent grant from a national funding agency!! Thank you #SERB, #serbpower, @Sandeep_1966
The Indian National Science Academy (INSA), in collaboration with the National Centre for Good Governance (NCGG), successfully concluded the 7th edition of LEADS on 27th September 2026. The valedictory session was graced by Shri Bharat Lal, Former Secretary General and CEO, NHRC.
The second lecture of the day at LEADS 7.0 was delivered by Prof. Shekhar Mande, President, INSA on “Leading Large Scientific Organisations with Compassion and Empathy.” @shekhar_mande@IndiaDST@NCGG_GoI
Identification of benzimidazole-6-carboxamide based inhibitors of secretory glutaminyl cyclase for the treatment of Alzheimer's disease - ScienceDirect https://t.co/c5AJzArXSt
Congratulations 👏
Mrs. Geethu S Nair, Junior Research Fellow in the SERB-POWER project under Dr. Divya M S, Scientist-C in the Dept of Pathology, Hospital Wing, SCTIMST for winning the Best poster presentation award. 👏💐
Congratulations 👏
Mrs. Geethu S Nair, Junior Research Fellow in the SERB-POWER project under Dr. Divya M S, Scientist-C in the Dept of Pathology, Hospital Wing, SCTIMST for winning the Best poster presentation award. 👏💐
Dr MS Valiathan, founder of the Sri Chitra Institute in Trivandrum, passed away today. A wonderful man, he had many stories to tell. One he told me was on how the institute obtained an iconic old palace as its headquarters. A small thread.
Padma Vibhushan Dr. M. S. Valiathan, renowned cardiac surgeon and founder Director SCTIMST taken to eternity on 17.07.2024 (9.14 pm) in Manipal. He served our institute from 01.01.1979 to 31.05.1994
The institute pays its sincere homage to the memory of Dr. M. S. Valiathan 🙏
Congratulations💐
Dr. Harikrishna Varma P.R., Head, BMT Wing, SCTIMST has been elected as Fellow of Biomaterials Science and Engineering (FBSE) in 2024 by the International Union of Societies For Biomaterials Science and Engineering (IUSBSE). 👏
A beautiful elephant family sleeps blissfully somwhere in deep jungles of the Anamalai Tiger Reserve in Tamil Nadu. Observe how the baby elephant is given Z class security by the family. Also how the young elephant is checking the presence of other family members for reassurance. So similar to our own families isn't it
Video @dhanu_paran for @tnforestdept #elephants #TNForest
Today, I’m thrilled have our lab’s work featured on the cover of @Nature
In this article, we have developed a therapeutic approach for a severe condition called Timothy syndrome. This has been a long journey. It started with making hiPS cell-derived neurons in 2D cultures 15 years ago when I was a postdoc and continued with later creating in the lab #organoid and then #assembloid models of this disease caused by a mutation in a calcium channel.
Over time, these human cellular models and the biological insights we gained enable us to design a therapeutic strategy, which we validated in vivo following circuit integration of patient-derived organoids into the rat brain.
Grateful for the incredible work led by @XiaoyuChenxy and @fikribirey in the lab! And the many close collaborators who participated to this line of research over the years.
Come work with us!!! We are looking for a highly motivated postdoctoral fellow to join our team at Cincinnati Children's Hospital and contribute to cutting-edge research in neuroscience. 1/2
I, along with Dr. M Mohanty, Head of the Autonomous Institution Division of DST, visited the engineering labs, biology labs, the new hospital block, the biobank, and materials research labs, and interacted with the Director of SCTIMST, Dr. Sanjay Behari, as well as the senior scientists.
Our latest out today in @Nature. We profiled 12 million single cells from mouse embryos spanning gastrulation to birth, defined cell type tree from zygote to birth, and unexpectedly found crazy fast changes within first hour of extrauterine life. OA PDF: https://t.co/7PsCcqaQS8
ℹ️ World's first CRISPR based medicine gets approval in UK
MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia
Casgevy (exagamglogene autotemcel) is based on the innovative gene-editing tool CRISPR.